Ultralife CorporationULBINASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -1.56% | +21.03% | +12.98% | +21.51% | +10.56% |
| Gross Profit Growth | -7.04% | +11.12% | +0.33% | +10.79% | +13.75% |
| EBITDA Growth | -45.76% | -5.14% | -28.58% | -56.58% | +10.35% |
| Operating Income Growth | -59.61% | -16.34% | -42.40% | -286.11% | +6.85% |
| Net Income Growth | -93.25% | -35.49% | -70.39% | -572.87% | -3925.77% |
| EPS Growth | -93.50% | -38.89% | -70.67% | -572.90% | -3946.15% |
| EPS Diluted Growth | -93.18% | -38.89% | -70.67% | -579.08% | -3979.31% |
| Weighted Average Shares Growth | +1.78% | +1.45% | +0.40% | +0.13% | +0.15% |
| Weighted Average Shares Diluted Growth | +1.75% | +0.98% | -1.00% | -1.35% | -0.67% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +25.25% | +0.00% | -33.50% | -96.33% | +0.00% |
| Free Cash Flow Growth | +70.99% | +0.00% | -43.55% | -119.77% | +0.00% |
| Receivables Growth | -7.53% | +2.22% | +4.08% | +11.44% | +15.59% |
| Inventory Growth | +21.67% | +9.20% | +22.19% | +19.90% | +5.15% |
| Asset Growth | +23.66% | +23.93% | +30.12% | +28.88% | -1.61% |
| Book Value per Share Growth | +5.04% | +4.36% | +3.51% | +1.94% | -3.13% |
| Debt Growth | +100.22% | +103.43% | +235.95% | +346.18% | -14.96% |
| R&D Expense Growth | +30.35% | +36.90% | +16.07% | +35.89% | +16.86% |
| SG&A Expenses Growth | +13.73% | +22.85% | +24.39% | +27.10% | +14.14% |